Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

7.41
Delayed Data
As of Aug 28
 -0.14 / -1.85%
Today’s Change
1.46
Today|||52-Week Range
11.65
+368.99%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close7.55
Today’s open7.18
Day’s range7.01 - 7.55
Volume707,715
Average volume (3 months)1,416,749
Market cap$294.2M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+19.53%
Earnings growth (this year)+19.85%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
POZNPOZEN Inc+0.02+0.23%
CPRXCatalyst Pharmaceuti...-0.02-0.55%
PTXPernix Therapeutics ...+0.10+2.17%
CCXIChemoCentryx Inc-0.39-5.66%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$29.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts

Partner Offers